The rise of Sildenafil initially fueled a surge for major pharmaceutical companies, however recent shifts present a complicated outlook for shareholders. Generic competitors are eroding earnings, and ongoing legal https://emiliekxik422455.ageeksblog.com/39610213/sildenafil-and-pharma-a-precarious-investment